No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
LBX Pharmacy Chain Joint Stock Company, headquartered in Changsha, China, oversees a substantial network of retail pharmacies throughout the country. Its operations span 21 distinct provincial markets across China, encompassing regions such as Hunan, Jiangsu, Gansu, Shaanxi, Guangxi, Anhui, Zhejiang, Inner Mongolia, Hubei, Tianjin, Henan, Shanghai, Shandong, Guangdong, Hebei, Beijing, Jiangxi, Ningxia, Sichuan, Fujian, and Guizhou. The company, which commenced operations in 2001, was originally incorporated under the name Laobaixing Pharmacy Chain Joint Stock Company.
www.lbxdrugs.comNo one on the platform currently holds 603883.SS.
No tracked institution reports a position in 603883.SS as of their last filing.
No one on the platform has traded 603883.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.7% | 8.6% | 11.7% | — | — | — |
| Rev. Growth % | -0.5% | 9.7% | ||||
| Profit Margin % | 1.7% | 3.3% | 4.0% | |||
| Free Cash Flow Margin % | 13.0% | 10.1% | 6.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $23.6B | +4.9% | $0.89 | $0.72–$1.08 | — | 7 |
| 2027 | $25.6B | +8.4% | $1.03 | $0.79–$1.28 | — | 7 |
| 2028 | $27.8B | +8.5% | $1.18 | $0.80–$1.85 | — | 11 |
| 2029 | $35.1B | +26.6% | $1.72 | $1.59–$1.96 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-28 | $0.20 | $0.24 | +20.0% |
| 2026-04-24 | $0.34 | $0.35 | +1.9% |
| 2026-04-22 | $0.33 | $-0.19 | -159.4% |
| 2025-10-28 | $0.19 | $0.17 | -7.9% |
| 2025-08-25 | $0.25 | $0.19 | -23.3% |
| 2025-04-29 | $0.24 | $0.15 | -37.5% |
| 2025-04-29 | $0.29 | $-0.15 | -151.7% |
| 2024-10-29 | $0.27 |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 603883.SSLBX Pharmacy Chain Joint Stock Company | $12.65 | -1.25% | $9.6B | — |
| 000028.SZChina National Accord Medicines Corporation Ltd. | $19.65 | -0.76% | $10.5B | — |
| 002626.SZXiamen Kingdomway Group Company | $16.18 | +0.25% | $9.9B | — |
| 300294.SZChina Resources Boya Bio-pharmaceutical Group Co., Ltd. | $13.96 | +0.14% | $7.0B | — |
| 600267.SSZhejiang Hisun Pharmaceutical Co., Ltd. |
| $0.17 |
| -37.0% |
| $11.37 |
| +0.62% |
| $13.4B |
| — |
| 600285.SSHenan Lingrui Pharmaceutical Co., Ltd. | $19.07 | -1.04% | $10.8B | — |
| 600993.SSMayinglong Pharmaceutical Group Co., Ltd. | $22.25 | -0.36% | $9.6B | — |
Source: Financial Modeling Prep · peers by sector/industry